Bruce W. Bode

26.9k total citations · 7 hit papers
242 papers, 14.6k citations indexed

About

Bruce W. Bode is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Bruce W. Bode has authored 242 papers receiving a total of 14.6k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Endocrinology, Diabetes and Metabolism, 122 papers in Surgery and 69 papers in Genetics. Recurrent topics in Bruce W. Bode's work include Diabetes Management and Research (212 papers), Diabetes Treatment and Management (121 papers) and Pancreatic function and diabetes (121 papers). Bruce W. Bode is often cited by papers focused on Diabetes Management and Research (212 papers), Diabetes Treatment and Management (121 papers) and Pancreatic function and diabetes (121 papers). Bruce W. Bode collaborates with scholars based in United States, Denmark and United Kingdom. Bruce W. Bode's co-authors include Paul C. Davidson, R. Dennis Steed, Timothy S. Bailey, Satish K. Garg, Richard M. Bergenstal, Irl B. Hirsch, Robert E. Ratner, Alan J. Garber, Andrew Lewin and Mark P. Christiansen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Bruce W. Bode

236 papers receiving 13.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

2008 882 citations Bruce W. Bode et al. profile →
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

2015 793 citations Melanie J. Davies, Richard M. Bergenstal et al. profile →
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

2015 519 citations Timothy S. Bailey, Bruce W. Bode et al. Diabetes Technology & Therapeutics profile →
Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

2020 503 citations Bruce W. Bode, Valerie Garrett et al. Journal of Diabetes Science and Technology profile →
Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia

2013 428 citations Richard M. Bergenstal, David C. Klonoff et al. New England Journal of Medicine profile →
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

2017 415 citations Satish K. Garg, Bruce A. Buckingham et al. Diabetes Technology & Therapeutics profile →
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus

2021 179 citations Jennifer L. Sherr, Bruce W. Bode et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bruce W. Bode	12.8k	6.9k	4.9k	2.3k	1.1k	242	14.6k
J. Hans DeVries	8.6k 0.7×	4.2k 0.6×	3.0k 0.6×	1.7k 0.8×	449 0.4×	235	13.1k
David M. Maahs	12.7k 1.0×	7.2k 1.0×	7.3k 1.5×	971 0.4×	345 0.3×	369	17.5k
David M. Nathan	12.3k 1.0×	4.3k 0.6×	4.2k 0.9×	2.3k 1.0×	494 0.4×	124	17.1k
Stephen C. Bain	7.3k 0.6×	3.6k 0.5×	2.9k 0.6×	3.5k 1.6×	1.3k 1.1×	251	11.7k
Éric Renard	6.0k 0.5×	4.1k 0.6×	3.4k 0.7×	899 0.4×	167 0.1×	264	8.9k
Tim Heise	10.2k 0.8×	6.0k 0.9×	2.7k 0.6×	2.3k 1.0×	700 0.6×	233	11.9k
David R. Owens	6.4k 0.5×	2.7k 0.4×	1.8k 0.4×	2.1k 0.9×	386 0.3×	274	10.1k
Eelco J.P. de Koning	2.7k 0.2×	3.9k 0.6×	2.1k 0.4×	3.9k 1.7×	439 0.4×	234	10.5k
George Grunberger	6.9k 0.5×	3.5k 0.5×	1.7k 0.3×	3.2k 1.4×	818 0.7×	161	10.9k
Jan Bolinder	6.2k 0.5×	4.2k 0.6×	3.2k 0.7×	1.6k 0.7×	557 0.5×	193	10.0k

Countries citing papers authored by Bruce W. Bode

Since Specialization

Citations

This map shows the geographic impact of Bruce W. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce W. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce W. Bode more than expected).

Fields of papers citing papers by Bruce W. Bode

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce W. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce W. Bode. The network helps show where Bruce W. Bode may publish in the future.

Co-authorship network of co-authors of Bruce W. Bode

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce W. Bode. A scholar is included among the top collaborators of Bruce W. Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce W. Bode. Bruce W. Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbour, Linda A., et al.. (2025). Inhaled insulin in pregnancy: A case series supporting feasibility and clinical potential for pregnant people with diabetes. SHILAP Revista de lepidopterología. 1(5). 1 indexed citations

Bhargava, Anuj, Richard M. Bergenstal, Mark Warren, et al.. (2025). Safety and Effectiveness of MiniMed ^TM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes. Diabetes Technology & Therapeutics. 27(5). 366–375. 3 indexed citations

Bailey, Timothy S., et al.. (2023). Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range. Diabetes Therapy. 14(5). 883–897. 4 indexed citations

Hood, Korey K., William H. Polonsky, Sarah A. MacLeish, et al.. (2023). Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers. Pediatric Diabetes. 2023. 1–12. 6 indexed citations

Bajaj, Harpreet S., Jens Aberle, Melanie J. Davies, et al.. (2023). Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5). Annals of Internal Medicine. 176(11). 1476–1485. 57 indexed citations

Bode, Bruce W., Valerie Garrett, Jordan Messler, et al.. (2020). Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. Journal of Diabetes Science and Technology. 14(4). 813–821. 503 indexed citations breakdown →

Eckstein, Max L., Sam N. Scott, Federico Y. Fontana, et al.. (2020). Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational study. BMJ Open Diabetes Research & Care. 8(1). e001245–e001245. 15 indexed citations

Bode, Bruce W., Eda Cengiz, R. Paul Wadwa, et al.. (2020). Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study. Diabetes Technology & Therapeutics. 23(1). 59–69. 16 indexed citations

Bode, Bruce W., Violeta Iotova, М. А. Коваренко, et al.. (2019). Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial. Diabetes Care. 42(7). 1255–1262. 46 indexed citations

10.

Klonoff, David C., et al.. (2019). Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes. Diabetes Care. 42(11). 2154–2157. 19 indexed citations

11.

Buse, John B., Satish K. Garg, Julio Rosenstock, et al.. (2018). Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 41(9). 1970–1980. 172 indexed citations

12.

Aktürk, Halis Kaan, Janet K. Snell‐Bergeon, Leslie J. Klaff, et al.. (2018). Improved Postprandial Blood Glucose (PPBG) Excursions with Technosphere Inhaled Insulin (TI) Compared with Aspart in T1D Patients—STAT Study. Diabetes. 67(Supplement_1). 1 indexed citations

13.

Wood, Michael A., Dorothy I. Shulman, Gregory P. Forlenza, et al.. (2018). In-Clinic Evaluation of the MiniMed 670G System “Suspend Before Low” Feature in Children with Type 1 Diabetes. Diabetes Technology & Therapeutics. 20(11). 731–737. 18 indexed citations

14.

Aktürk, Halis Kaan, Janet K. Snell‐Bergeon, Leslie J. Klaff, et al.. (2018). Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. Diabetes Technology & Therapeutics. 20(10). 639–647. 40 indexed citations

15.

Snell‐Bergeon, Janet K., Halis Kaan Aktürk, Bruce W. Bode, et al.. (2018). Improved Time-in-Range (TIR) on Continuous Glucose Monitor (CGM) with Technosphere Inhaled Insulin (TI) Compared with Insulin Aspart in T1D Patients—STAT Study. Diabetes. 67(Supplement_1). 1 indexed citations

16.

Aleppo, Grazia, Katrina J. Ruedy, Tonya D. Riddlesworth, et al.. (2017). REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes. Diabetes Care. 40(4). 538–545. 236 indexed citations

17.

Bode, Bruce W., et al.. (2015). Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial. Diabetes Care. 38(12). 2266–2273. 67 indexed citations

18.

Bailey, Timothy S., Bruce W. Bode, Mark P. Christiansen, Leslie J. Klaff, & Shridhara Alva. (2015). The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technology & Therapeutics. 17(11). 787–794. 519 indexed citations breakdown →

19.

Bergenstal, Richard M., David C. Klonoff, Satish K. Garg, et al.. (2013). Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia. New England Journal of Medicine. 369(3). 224–232. 428 indexed citations breakdown →

20.

Hirsch, Irl B., Stephanie A. Amiel, Ian Blumer, et al.. (2012). Using Multiple Measures of Glycemia to Support Individualized Diabetes Management: Recommendations for Clinicians, Patients, and Payers. Diabetes Technology & Therapeutics. 14(11). 973–983. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact